Ring vaccination may not be effective against monkeypox: Study
Published By : Prameya News Bureau | August 07, 2022 IST
Share
New Delhi, Aug 7 (IANS): Even as the health experts from around the globe have been stressing on the need to implement ring vaccination among the people at risk with monkeypox, a new study, not peer-reviewed yet, has claimed that the strategy may not be completely effective in curbing the current outbreak. Ring vaccination, which has been used successfully to contain smallpox and Ebola outbreaks, means to vaccinate a "ring" of people around the infected rather than vaccinating an entire population, ideally within four days of exposure. The study led by a team, including from Universite Paris Cite in France, showed that ring vaccination may not completely protect against infections. The findings were based on a third-generation smallpox vaccine recommended in France for individuals who had a high-risk contact with a PCR-confirmed Monkeypox patient. The study aimed to describe the outcomes of high-risk contacts receiving third-generation smallpox vaccine as an early post-exposure ring vaccination (EPRV) especially tolerance and potential breakthrough infections after the first dose. The team performed an observational analysis of all consecutive individuals vaccinated with the IMVANEX smallpox vaccine after a high-risk contact. It was defined as close skin-to-skin or mucosal contact and/or indirect contact on textile or surface and/or droplets exposure defined by a contact at less than 2 meters during at least 3 hours with a PCR-confirmed Monkeypox patient. Between May 27 and July 13, 276 individuals received one dose of IMVANEX with a median delay of 11 days after exposure with a confirmed Monkeypox patient. Mode of exposure was droplets for 240 patients (91 per cent), indirect contact for 189 (71 per cent) and unprotected sexual intercourse for 146 (54 per cent). Most of the patients were men (91 per cent) and men who have sex with men (88 per cent). The vaccine was well tolerated with no severe adverse event. Among the 276 vaccinated individuals, 12 (4 per cent) had a confirmed Monkeypox breakthrough infection with no severe infection. Ten out of 12 patients developed a Monkeypox infection in the five days following vaccination and two had a breakthrough infection at 22 and 25 days. "EPRV with a third-generation smallpox vaccine was well tolerated and effective against Monkeypox but did not completely prevent breakthrough infections," the researchers wrote in the paper posted online.
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
Drugs worth Rs 3.5 cr concealed in pumpkins seized in Manipur
Supreme Court's verdict on pleas seeking mandatory EVM-VVPAT tally tomorrow
Deadline for filing 10A/10AB forms extended upto 30th June
PM Modi lambasts Congress, says Rajiv Gandhi abolished inheritance law to 'save own interests'
Telangana CM Revant Reddy alleges conspiracy to stop reservations in the country
EC sends notice to BJP over MCC violation by PM Modi
Lok Sabha polls: ECI takes cognizance of MCC violations by Rahul Gandhi
PM Modi accuses Congress of "tying hands of soldiers", says we have given full freedom to retaliate
Lok Sabha polls: NCP(SP)’s manifesto promises Rs 1 lakh/year dole to poor women & jobless youth
JDU youth leader shot dead in Bihar’s Patna
Lok Sabha polls: PM Modi to campaign in MP, UP today
Karnataka's Election Commission plans 1,832 special polling booths for inclusive voting
Bridge connecting to Manipur damaged by IED blasts
BRS chief KCR starts 17-day bus yatra to boost party campaign ahead of polls
All three units of EVMs have their own microcontroller: SC informed
India to become one of biggest semiconductor hubs in next 5 years: Vaishnaw
PM Modi advocates for resilient infrastructure at 39-nation meet on natural disasters
Supreme Court to issue directions on mandatory VVPAT verification
PM Modi to address public meetings in Chhattisgarh, MP today